Abstract The 1, 2, 4-triazolo [1, 5-a] pyrimidine (TP) heterocycle, in spite of its relatively
simple structure, has proved to be remarkably versatile as evidenced by its use in many …

In the search of significant biological agents for the pathogenic causing deformities, four
bidentate heterocyclic Schiff base ligands and their sixteen Co (II), Ni (II), Cu (II) and Zn (II) …

Abstract The [1, 2, 4] triazolo [1, 5-a] pyrimidines (TPs) comprise an important class of non-
naturally occurring small molecules that aroused the interest of researches. This scaffold is …

The review deals with the pharmaceutically and agrochemically important group of 1, 2, 4-
triazolo [1, 5-a] pyrimidines (TPs) and covers relevant literature published from about 2006 …

Leishmaniasis and Chagas disease are still considered neglected illnesses due to the lack
of investment in research, despite the fact that almost one million new cases are reported …

In this study cytotoxicity of organotin (IV) compounds with 1, 2, 4-triazolo [1, 5-a] pyrimidines,
Me3Sn (5tpO)(1), n-Bu3Sn (5tpO)(2), Me3Sn (mtpO)(3), n-Bu3Sn (mtpO)(4), n-Bu3Sn …

Two triazolopyrimidine complexes have been obtained from reaction between 7-amino-1, 2,
4-triazolo [1, 5-a] pyrimidine (7atp) and Cu (II) salts. Crystal structures of [Cu 2 (μ-7atp) 4 Cl …

Leishmaniasis is a complex disease present in a variety of manifestations listed by the World
Health Organization (WHO) as one of the neglected diseases with a worse prognosis if not …

In order to improve the previously observed antichagasic activity of Cu (II) complexes
containing 2-chlorobenzhydrazide (2-CH), we report herein the synthesis and anti …

1, 2, 4-Triazole moieties have been incorporated into a wide variety of therapeutically
interesting drug candidates including central nervous system stimulants, sedatives …